|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.15 CNY | +2.00% |
|
+8.61% | -15.69% |
Zhejiang Orient Gene Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 8,736.12 million compared to CNY 10,169.17 million a year ago. Net income was CNY 2,980.21 million compared to CNY 4,920.19 million a year ago.
Basic earnings per share from continuing operations was CNY 14.7833 compared to CNY 24.4048 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.69% | 823M | |
| -1.19% | 12.56B | |
| -6.06% | 7.68B | |
| -0.28% | 5.29B | |
| +22.15% | 5.24B | |
| +2.05% | 4.57B | |
| -50.80% | 3.29B | |
| +7.80% | 2.6B | |
| -8.63% | 2.2B | |
| -0.96% | 1.79B |
ZHEJIANG ORIENT GENE BIOTECH CO.,LTD 